Several cancers, including ovarian, cervical, testicular, kidney, and lung, often present no early symptoms, leading to ...

AIIMS Delhi has developed a blood test using ddPCR tech to detect HPV DNA for early cervical cancer detection, relapse ...

Updated phase 3 data support pembrolizumab plus concurrent chemoradiotherapy as a standard of care for patients with high-risk, locally advanced cervical cancer, according to Linda Duska, MD.

Cervical cancer is a type of cancer that originates in the cervix—the lower part of the uterus that connects to the vagina.

Universiti Sains Malaysia (USM) has established a Clinical Specialist and Cancer Research Centre at the Institute of Advanced ...

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

The Japanese Ministry of Health, Labour and Welfare on Thursday approved Genmab A/S’ (NASDAQ:GMAB) Tivdak (tisotumab vedotin) for advanced or recurrent cervical cancer that has progressed on or ...

KSQ-004EX is being evaluated in solid tumors including melanoma, non-small cell lung, head and neck, colorectal, pancreatic ...

A recent AIIMS, Delhi study reveals that removing specific lymph nodes from the pelvis and abdomen significantly improves ...

Today, cervical cancer is highly treatable if detected early — but the challenge is that the disease often shows no symptoms until it has already advanced. This makes it crucial to stay on top ...

A breakthrough in cancer treatment may soon change how some of the most aggressive tumors are managed. A small, ...

Japan approves Tivdak, the first ADC for cervical cancer ... TIVDAK compared to chemotherapy in patients with advanced or recurrent cervical cancer who were previously treated with chemotherapy.